Prelude Therapeutics Statistics
Total Valuation
PRLD has a market cap or net worth of $222.46 million. The enterprise value is $34.14 million.
| Market Cap | 222.46M |
| Enterprise Value | 34.14M |
Important Dates
The last earnings date was Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PRLD has 54.93 million shares outstanding. The number of shares has increased by 58.65% in one year.
| Shares Outstanding | 54.93M |
| Shares Change (YoY) | +58.65% |
| Shares Change (QoQ) | +8.83% |
| Owned by Insiders (%) | 9.07% |
| Owned by Institutions (%) | 95.06% |
| Float | 13.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.06 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.64, with a Debt / Equity ratio of 0.08.
| Current Ratio | 11.64 |
| Quick Ratio | n/a |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.00% and return on invested capital (ROIC) is -60.21%.
| Return on Equity (ROE) | -53.00% |
| Return on Assets (ROA) | -47.20% |
| Return on Capital (ROIC) | -60.21% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$980,820 |
| Employee Count | 128 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.51% in the last 52 weeks. The beta is 1.55, so PRLD's price volatility has been higher than the market average.
| Beta (1Y) | 1.55 |
| 52-Week Price Change | -36.51% |
| 50-Day Moving Average | 4.35 |
| 200-Day Moving Average | 3.59 |
| Relative Strength Index (RSI) | 48.90 |
| Average Volume (30 Days) | 51,374 |
Short Selling Information
The latest short interest is 630,563, so 1.15% of the outstanding shares have been sold short.
| Short Interest | 630,563 |
| Short Previous Month | 604,040 |
| Short % of Shares Out | 1.15% |
| Short % of Float | 4.62% |
| Short Ratio (days to cover) | 13.95 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -137.51M |
| Pretax Income | -125.55M |
| Net Income | -125.55M |
| EBITDA | -122.31M |
| EBIT | -125.55M |
| Earnings Per Share (EPS) | -$1.88 |
Balance Sheet
The company has $205.97 million in cash and $17.64 million in debt, giving a net cash position of $188.33 million or $3.43 per share.
| Cash & Cash Equivalents | 205.97M |
| Total Debt | 17.64M |
| Net Cash | 188.33M |
| Net Cash Per Share | $3.43 |
| Equity / Book Value | 210.73M |
| Book Value Per Share | 3.84 |
| Working Capital | 187.72M |
Cash Flow
In the last 12 months, operating cash flow was -$108.72 million and capital expenditures -$2.99 million, giving a free cash flow of -$111.71 million.
| Operating Cash Flow | -108.72M |
| Capital Expenditures | -2.99M |
| Free Cash Flow | -111.71M |
| FCF Per Share | -$1.48 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PRLD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -58.65% |
| Shareholder Yield | -58.65% |
| Earnings Yield | -56.43% |
| FCF Yield | -50.22% |
Analyst Forecast
The average price target for PRLD is $5.25, which is 31.25% higher than the current price. The consensus rating is "Hold".
| Price Target | $5.25 |
| Price Target Difference | 31.25% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -9.84% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |